Sanofi and Luminostics to create cell-phone based test for Covid-19 Kumar Jeetendra | April 18, 2020 Sanofi has started working with California startup Luminostics to construct an at-home test for COVID-19 that would utilize an example peruser fueled by a client’s close to home cell phone. Utilizing a connector that cuts via telephone’s camera and flashbulb, Luminostics’ minimal effort, reusable gadget contains synthetic substances that faintly shine in obscurity when certain …
Jubilant Life Sciences invalidates Karnataka minister’s claim Kumar Jeetendra | April 16, 2020 Jubilant Life Sciences discredits Karnataka priest’s case that coronavirus positive representative made a trip to China The inquisitive instance of the coronavirus bunch episode among the representatives of pharmaceutical firm Jubilant Generics at its Mysuru plant took a new turn on Thursday, with the organization invalidating charges by Karnataka state specialists that the state’s COVID-19 …
Screening test proves effectiveness of various MicroSilver BG™ products against viruses Kumar Jeetendra | April 15, 2020 Nuremberg, April 15th 2020 – Bio-Gate AG (ISIN DE000BGAG981), one of the leading providers of innovative technologies and solutions for health and hygiene, has proven in a screening test in cooperation with a renowned and certified test laboratory in Germany, that MicroSilver BG™ and various products that contain MicroSilver BG™ are effective against enveloped viruses. …
HALIX Enters partners with the University of Oxford for GMP Manufacturing of a COVID-19 Vaccine Kumar Jeetendra | April 15, 2020 HALIX B.V. has joined a consortium of accomplices under the direction of the University of Oxford, to give GMP fabricating administrations supporting the huge scope creation of a COVID-19 immunization (ChAdOx1 nCoV-19), being created by the University’s Jenner Institute. This GMP producing scale-up is occurring nearby early stage clinical preliminaries. The preliminaries are significant in …
Collaborative Effort Delivers Life-Saving Breathing Aid Kumar Jeetendra | April 15, 2020 A breathing aid that can help keep Covid-19 patients out of intensive care, has been developed in just 5 days by mechanical engineers at University College London and clinicians at University College London Hospital working in conjunction with Mercedes-AMG High Performance Powertrains. The breathing aid, known as a Continuous Positive Airway Pressure (CPAP), has been …
Vault Health Launches Saliva-based FDA EUA Approved Test for COVID-19 Kumar Jeetendra | April 15, 2020 Vault Health, a startup spend significant time in human services for men, has gone concentration to help satisfy interest for hard to get COVID-19 tests in 48 states by working with RUCDR Infinite Biologics to give a first-of-its-sort FDA EUA-endorsed spit test for COVID-19. “This is not our core business, but we built our healthcare …
GSK and Sanofi accomplice to create antibody against covid-19 Kumar Jeetendra | April 14, 2020 In an uncommon coordinated effort, French biopharmaceutical company Sanofi and its British opponent GlaxoSmithKline plc (GSK) have banded together to build up an immunization against covid-19, which if fruitful, will be popularized in the second 50% of one year from now, the French firm said in a discharge. “This cooperation unites two of the world’s …
You should know what is Aarogya Setu application, how it helps battle coronavirus Kumar Jeetendra | April 14, 2020 Prime minister Narendra Modi in his speech to the country on Tuesday morning asked to download the ‘Aarogya Setu App’. Thus, we should comprehend what this application is about. This application is intended to help control the spread of coronavirus and make its data open to the ordinary citizens. This unique application additionally helps in …
Dr Reddy’s introduces generic cancer drug Invista in india Kumar Jeetendra | April 13, 2020 Pharma major Dr Reddy’s Laboratories Ltd has propelled Invista. It is a detailing of Dasatinib that is bioequivalent to the pioneer brand. Patent on Dasatinib is possessed by Bristol-Myers-Squibb. The Indian patent has lapsed on April 12, 2020. It is demonstrated for the treatment of ceaseless quickened or myeloid or lymphoid impact stage and recently …
Cipla receives final approval for generic version of inhalation drug Kumar Jeetendra | April 9, 2020 Mumbai, India; April 9, 2020: Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as “Cipla”) today announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Albuterol Sulfate Inhalation Aerosol 90mcg (base)/actuation, from the United States Food and Drug Administration (US FDA). Cipla’s Albuterol Sulfate Inhalation Aerosol …
West Pharmaceutical Names Stewart Campbell Vice President & General Manger for Asia Pacific Region Kumar Jeetendra | April 8, 2020 West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, recently named Stewart Campbell as the Vice President & General Manager for the Asia Pacific region. Stewart brings more than 25 years of organizational leadership in the food, pharmaceutical and dietary supplement industries, with extensive Asia Pacific management expertise. …
World First Clinical Study of iPSC-derived Corneal Epithelial Cells Kumar Jeetendra | April 6, 2020 AMSBIO report on a world first clinical study of iPSC-derived corneal epithelial cells by Professor Ryuhei Hayashi and co-workers from the Graduate School of Medicine, Osaka University, Japan using StemFit Basic03 clinical grade stem cell culture medium and iMatrix-511 recombinant laminin E8 fragments. In this ground-breaking work, corneal epithelial sheets from HLA-homozygous iPS cells were …
